Back to All Ideas
Stock Analysis·1:51 PM ET · May 13, 2026·4 min read

Today's Top Stock Highlights — May 13, 2026

NASDAQ:ALTNASDAQ:CSCONASDAQ:IMUXNYSE:VSHNASDAQ:NVDANASDAQ:MSFTNYSE:FDSNASDAQ:ZBRA

Alpha Stocks Insight Staff

Independent stock news and analysis covering NASDAQ and NYSE markets.

Share

A roundup of today's most significant stock moves and news across the market.

Today's Top Stock Highlights — May 13, 2026

Altimmune Inc. (ALT) declined 3.57% to $2.97 as the biotech company reported its first quarter 2026 financial results alongside a business update. The stock's weakness comes despite the company advancing its pipeline, as Altimmune is set to present results of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH) during an oral presentation at EASL Congress 2026, alongside multiple poster presentations. The clinical data presentation represents a key milestone for the company's therapeutic efforts in the MASH space, though investor sentiment remained cautious heading into the announcements.

Cisco Systems Inc. (CSCO) edged higher by 0.56% to $99.85 in a market broadly leaning upward ahead of producer price index data. The networking giant is gearing up for its third quarter earnings print, with Wall Street's most accurate analysts recently adjusting their forecasts on the stock. Attention to Cisco also reflects broader market focus on China-related trade dynamics, particularly following developments around Trump's China visit, which continues to influence investor positioning in large-cap technology names.

Immunic Inc. (IMUX) slipped 0.67% to $11.82 following the release of the company's first quarter 2026 news release and investor presentation. The biopharmaceutical firm provided updates on its pipeline and financial position as it continues to advance its portfolio of immunology-focused therapies. The modest decline suggests investors are digesting the latest corporate disclosures before determining their next moves in the small-cap biotech sector.

Vishay Intertechnology Inc. (VSH) surged 8.03% to $36.33, marking the day's strongest performer among the covered stocks after reporting first quarter 2026 results. The components manufacturer's solid financial metrics and operational performance in the latest quarter drove investor optimism, with the company's Q1 presentation highlighting positive trends in revenue and profitability. The significant upside move reflects renewed confidence in Vishay's execution and market positioning heading into the second half of 2026.

NVIDIA Corporation (NVDA) climbed 1.39% to $223.85 amid continued momentum in AI-related equities. Beyond NVIDIA's own strength, investor attention focused on a Nvidia-backed artificial intelligence stock that recently partnered with defense technology company Anduril, signaling ongoing expansion of AI capabilities across the industrial and defense sectors. The day's gains reinforce NVIDIA's position as a bellwether for the artificial intelligence trade, with ongoing comparisons to AMD underscoring competitive dynamics in the high-performance chip market.

Microsoft Corporation (MSFT) retreated 1.55% to $401.44, underperforming the broader strength in mega-cap tech names. Market discussion centered on the evolving software pricing landscape and broader infrastructure spending trends, exemplified by Nebius's AI-driven revenue growth. Microsoft's pullback may reflect profit-taking after recent strength or investor rotation toward other opportunities in the technology sector.

FactSet Research Systems Inc. (FDS) declined 3.36% to $208.67, posting the day's second-largest percentage loss among the covered stocks. While the financial data and analytics provider did not make headlines for company-specific developments, the broader market environment and sector dynamics appear to have weighed on sentiment toward the stock. FactSet remains a key infrastructure player for institutional investors, though near-term momentum has turned negative.

Zebra Technologies Corporation (ZBRA) fell 1.54% to $238.06 despite the company's Q1 2026 earnings call highlighting strong revenue growth. Wall Street analyst research calls covering the enterprise mobility and data capture specialist pointed to solid operational performance, yet the stock still declined modestly, suggesting some profit-taking or mixed investor sentiment around valuation following the quarter's strong showing.

Key Takeaways

  • ALT: Biotech name lower ahead of MASH clinical data presentations at EASL Congress despite advancing pipeline efforts.
  • CSCO: Networking giant edges higher as market awaits economic data; third quarter earnings loom ahead.
  • IMUX: Immunology-focused biotech retreats slightly following Q1 results and investor presentation release.
  • VSH: Components manufacturer surges 8% on strong first quarter results and positive operational momentum.
  • NVDA: AI chip leader gains amid continued expansion of artificial intelligence partnerships and industry adoption.
  • MSFT: Software giant pulls back despite favorable infrastructure spending trends in the broader market.
  • FDS: Financial analytics provider faces headwinds with declining stock momentum in today's session.
  • ZBRA: Enterprise mobility specialist declines despite strong Q1 revenue growth highlighted in earnings call.
market roundupdaily highlightsMay 13, 2026

Found this useful? Share it:

Share

Related Articles

Important Legal Disclaimer

This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.

Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.

Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.